Dementia Basics part 3- June & July 2024- Research in Dementia with Dr. Andrew Frank

Dementia Basics-Part 3 Research in Dementia
1. How a diagnosis of dementia is made
2. Understanding the pathology
3. Advances in Diagnosis
4. Advances in Treatment
a) Research Challenges
b) What is a pathological cascade?
c) Correlation versus causation
d) Differentiating research on cells, rodents and humans
e) Clinical Trials and You
5. Services in the Region
6. Updates on Clinical Trials
7. Anti-amyloid therapy updates: Lecanemab and Donanemab
Our Speaker
Dr. Andrew R. Frank
MD, BSc (H), FRCP(C)
Cognitive and Behavioural Neurologist
Medical Director, Bruyère Memory Program
Élisabeth Bruyère Hospital
Dr. Andrew Frank is a cognitive and behavioural neurologist at Bruyère Memory Program at the Élisabeth Bruyère Hospital in Ottawa, Ontario.
After finishing his Bachelor’s degree in Honours Biochemistry at the University of Calgary, Dr. Frank completed his M.D. at the University of British Columbia in Vancouver. He completed his residency in Neurology at the University of Ottawa. Following this, Dr. Frank undertook a subspecialty fellowship in Cognitive and Behavioural Neurology at the Mayo Clinic in Rochester, Minnesota.
Dr. Frank’s clinical practice is focused on the diagnosis and treatment of neurodegenerative diseases, such as dementia due to Alzheimer’s disease. His clinical interest lies in the early detection of cognitive disorders, such as Mild Cognitive Impairment (MCI). Dr. Frank’s research interest centers on investigating new pharmacologic treatments and technologies for Alzheimer’s disease.
Host: German Chique-Alfonzo, MD, MHPE, Education Coordinator